Article
Establishment and characterization of a novel sinonasal adenosquamous carcinoma cell line, TC717, with a high tumor mutational burden.
Human cell - 24 Feb 2026
Kuga Ryosuke, Yamamoto Takeo, Iwasaki Takeshi, Taniguchi Midori, Manako Tomomi, Yamamoto Hidetaka, Oda Yoshinao
Abstract excerpt
We established and characterized a novel human sinonasal adenosquamous carcinoma (ASC) cell line, TC717, derived from a 64-year-old, never-smoking woman. The patient received neoadjuvant chemotherapy followed by total maxillectomy but succumbed to disease 6 months after therapy initiation. TC717 recapitulated the histologic and immunohistochemical hallmarks of ASC, including squamous differentiation (p40...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
